Satellos Bioscience Inc.
Desiree Chan currently serves as Chief of Staff at Satellos Bioscience Inc. since June 2023. Prior experience includes a role in Expansion Pack at Shopify from April 2021 to May 2023 and Associate Director of Philanthropy and Donor Engagement at Canadian Stage from September 2018 to April 2021. Earlier positions include Coordinator at The W. Garfield Weston Foundation with Wittington Investments Limited, Senior Development Officer at both the Rotman School of Management and the Leslie Dan Faculty of Pharmacy at the University of Toronto, Individual Giving Manager at Canadian Stage, and Development Manager at Victoria Symphony. Desiree Chan holds a Bachelor of Music from The University of British Columbia and completed the Income Managers Program at the University of Waterloo.
This person is not in any teams
Satellos Bioscience Inc.
Satellos is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Satellos was founded on the discovery that dysregulated muscle stem-cell polarity - a process that balances replenishment of muscle stem cells and production of specialized tissue cells- can lead to the inability of the body to properly repair and regenerate muscle throughout life. Satellos' lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease. Satellos believes defects in muscle regeneration play a critical underlying role in numerous muscle disorders spanning rare diseases through to mass market indications. Accordingly, Satellos applies its proprietary discovery platform, MyoReGenX, to identify regulatory pathways and drug candidates to treat muscle disorders where stem cell polarity is dysregulated.